BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27211051)

  • 1. From Genetic Predisposition to Molecular Mechanisms of Autoimmune Primary Adrenal Insufficiency.
    Falorni A; Brozzetti A; Perniola R
    Front Horm Res; 2016; 46():115-32. PubMed ID: 27211051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms and autoimmune Addison's disease.
    Falorni A; Brozzetti A; Torre DL; Tortoioli C; Gambelunghe G
    Expert Rev Clin Immunol; 2008 Jul; 4(4):441-56. PubMed ID: 20477573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies.
    Brozzetti A; Marzotti S; Tortoioli C; Bini V; Giordano R; Dotta F; Betterle C; De Bellis A; Arnaldi G; Toscano V; Arvat E; Bellastella A; Mantero F; Falorni A;
    Eur J Endocrinol; 2010 Feb; 162(2):361-9. PubMed ID: 19884265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple loci in the HLA complex are associated with Addison's disease.
    Skinningsrud B; Lie BA; Lavant E; Carlson JA; Erlich H; Akselsen HE; Gervin K; Wolff AB; Erichsen MM; Løvås K; Husebye ES; Undlien DE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1703-8. PubMed ID: 21816777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.
    Mitchell AL; Macarthur KD; Gan EH; Baggott LE; Wolff AS; Skinningsrud B; Platt H; Short A; Lobell A; Kämpe O; Bensing S; Betterle C; Kasperlik-Zaluska A; Zurawek M; Fichna M; Kockum I; Nordling Eriksson G; Ekwall O; Wahlberg J; Dahlqvist P; Hulting AL; Penna-Martinez M; Meyer G; Kahles H; Badenhoop K; Hahner S; Quinkler M; Falorni A; Phipps-Green A; Merriman TR; Ollier W; Cordell HJ; Undlien D; Czarnocka B; Husebye E; Pearce SH
    PLoS One; 2014; 9(3):e88991. PubMed ID: 24614117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.
    Ghaderi M; Gambelunghe G; Tortoioli C; Brozzetti A; Jatta K; Gharizadeh B; De Bellis A; Pecori Giraldi F; Terzolo M; Betterle C; Falorni A
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4107-11. PubMed ID: 16849401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease.
    Vaidya B; Imrie H; Geatch DR; Perros P; Ball SG; Baylis PH; Carr D; Hurel SJ; James RA; Kelly WF; Kemp EH; Young ET; Weetman AP; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):688-91. PubMed ID: 10690877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.
    Gambelunghe G; Falorni A; Ghaderi M; Laureti S; Tortoioli C; Santeusanio F; Brunetti P; Sanjeevi CB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3701-7. PubMed ID: 10523017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of primary adrenal insufficiency.
    Husebye E; Løvås K
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):147-57. PubMed ID: 19500759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles.
    Brønstad I; Skinningsrud B; Bratland E; Løvås K; Undlien D; Sverre Husebye E; Wolff AS
    Eur J Endocrinol; 2014 Dec; 171(6):743-50. PubMed ID: 25249698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.
    Badenhoop K; Walfish PG; Rau H; Fischer S; Nicolay A; Bogner U; Schleusener H; Usadel KH
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2112-7. PubMed ID: 7608264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I.
    Bøe Wolff AS; Oftedal B; Johansson S; Bruland O; Løvås K; Meager A; Pedersen C; Husebye ES; Knappskog PM
    Genes Immun; 2008 Mar; 9(2):130-6. PubMed ID: 18200029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.
    Myhre AG; Undlien DE; Løvås K; Uhlving S; Nedrebø BG; Fougner KJ; Trovik T; Sørheim JI; Husebye ES
    J Clin Endocrinol Metab; 2002 Feb; 87(2):618-23. PubMed ID: 11836294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the CYP27B1 C(-1260)A polymorphism with autoimmune Addison's disease.
    Fichna M; Zurawek M; Januszkiewicz-Lewandowska D; Gryczyñska M; Fichna P; Sowiñski J; Nowak J
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):544-9. PubMed ID: 19998245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA similarities indicate shared genetic risk in 21-hydroxylase autoantibody positive South African and United States Addison's disease.
    Ross IL; Babu S; Armstrong T; Zhang L; Schatz D; Pugliese A; Eisenbarth G; Baker Ii P
    Tissue Antigens; 2014 Oct; 84(4):361-9. PubMed ID: 25040682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility.
    Partanen J; Peterson P; Westman P; Aranko S; Krohn K
    Hum Immunol; 1994 Oct; 41(2):135-40. PubMed ID: 7860358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.
    Kemp EH; Ajjan RA; Husebye ES; Peterson P; Uibo R; Imrie H; Pearce SH; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):609-13. PubMed ID: 10197076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility.
    Mitchell AL; Cordell HJ; Soemedi R; Owen K; Skinningsrud B; Wolff AB; Ericksen M; Undlien D; Husebye E; Pearce SH
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5139-45. PubMed ID: 19850680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations.
    Gombos Z; Hermann R; Kiviniemi M; Nejentsev S; Reimand K; Fadeyev V; Peterson P; Uibo R; Ilonen J
    Eur J Endocrinol; 2007 Dec; 157(6):757-61. PubMed ID: 18057383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.
    Eriksson D; Røyrvik EC; Aranda-Guillén M; Berger AH; Landegren N; Artaza H; Hallgren Å; Grytaas MA; Ström S; Bratland E; Botusan IR; Oftedal BE; Breivik L; Vaudel M; Helgeland Ø; Falorni A; Jørgensen AP; Hulting AL; Svartberg J; Ekwall O; Fougner KJ; Wahlberg J; Nedrebø BG; Dahlqvist P; ; ; Knappskog PM; Wolff ASB; Bensing S; Johansson S; Kämpe O; Husebye ES
    Nat Commun; 2021 Feb; 12(1):959. PubMed ID: 33574239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.